Increased expression of serum amyloid A in glaucoma and its effect on intraocular pressure

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 5, 2008, Pages 1916-1923

  Wang, Wan Heng ^a   McNatt, Loretta G ^a   Pang, Iok Hou ^a   Hellberg, Peggy E ^a   Fingert, John H ^b   McCartney, Mitchell D ^a   Clark, Abbot F ^a  

^a ALCON RESEARCH LTD   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; INTERLEUKIN 8; MESSENGER RNA; RECOMBINANT PROTEIN; SERUM AMYLOID A; SERUM AMYLOID A 2; UNCLASSIFIED DRUG;

ADULT; AGED; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TISSUE PERFUSION; TRABECULAR MESHWORK; UPREGULATION; CELL CULTURE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; OPEN ANGLE GLAUCOMA; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN CULTURE TECHNIQUES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; TRABECULAR MESHWORK;

EID: 44649175298     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1104     Document Type: Article

References (38)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Leskea MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol. 2004;15:102-106.
3. Maier PC, Funk J, Schwarzer G, Antes G, Falck Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ. 2005;331:134.
4. Clark AF, Pang I-H. Advances in glaucoma therapeutics. Exp Opin Emerging rugs. 2002;7:141-163.
5. Clark AF, Yorio T. Ophthalmic drug discovery. Nat Rev Drug Discov. 2003;2:448-459.
6. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
7. Nguyen TD, Chen P, Huang WD, et al. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. JBiol Chem. 1998;273:6341-6350.
8. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabec- ular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10:117-125.
9. Joe MK, Sohn S, Hur W, et al. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabec- ular meshwork cells. Biochem Biophys Res Commun. 2003;312:592-600.
10. Shepard AR, Jacobson N, Millar JC, et al. Glaucoma-causing myo- cilin mutants require he peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007; 16:609-617.
11. Dickerson JE Jr, Steely HT Jr, English Wright SL, Clark AF. The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. ExpEye Res. 1998;66: 731-738.
12. Bhattacharya SK, Rockwood EJ, Smith SD, et al. Proteomics reveal Cochlin deposits associated with glaucomatous trabecular mesh-work. J Biol Chem. 2005;280:6080-6084.
13. Diskin S, Kumar J, Cao Z, et al. Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:1491-1499.
14. Lo WR, Rowlette LL, Caballero M, et al. Tissue differential microar- ray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci. 2003;44:473-485.
15. Liton PB, Luna C, Challa P, Epstein DL, Gonzalez P. Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Mol Vis. 2006;12:774-790.
16. Wang WH, McNatt LG, Shepard AR, et al. Optimal procedure for extracting RNA from human ocular tissues and expression profiling of the congenital glaucoma gene FOXC1 using quantitative RT-PCR. Mol Vis. 2001;7:89-94.
17. Tusher VG, Tibshirani R, Chu G. Significance analysis of microar- rays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121.
18. Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human tra- becular meshwork cells. Invest Ophthalmol VisSci. 1994;35:281-294.
19. Pang IH, McCartney MD, Steely HT, Clark AF. Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research. J Glaucoma. 2000;9:468-479.
20. Pang IH, Fleenor DL, Hellberg PE, et al. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest Ophthalmol Vis Sci. 2003;44: 3502-3510.
21. Ribeiro FP, Furlaneto CJ, Hatanaka E, et al. mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm. 2003;12:173-178.
22. Fautsch MP, Bahler CK, Jewison DJ, Johnson DH. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci. 2000;41:4163-4168.
23. Rozsa FW, Reed DM, Scott KM, et al. Gene expression profile of human trabecular meshwork cells in response to long-term dexa- methasone exposure. Mol Vis. 2006;12:125-141.
24. Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol Histopathol. 2005;20:1295-1307.
25. Liang JS, Sloane JA, Wells JM, et al. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett. 1997;225:73-76.
26. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501-523.
27. Baranova IN, Vishnyakova TG, Bocharov AV, et al. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen- activated protein kinases. J Biol Chem. 2005;280:8031-8040.
28. Jijon HB, Madsen KL, Walker JW, Allard B, Jobin C. Serum amyloid A activates NF-κB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur J Immunol. 2005;35: 718-726.
29. Vallon R, Freuler F, Desta Tsedu N, et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol. 2001;166:2801-2807.
30. Patel H, Fellowes R, Coade S, Woo P. Human serum amyloid A has cytokine-like properties. Scand J Immunol. 1998;48:410-418.
31. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun. 2000;268:405-408.
32. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci. 2003;8:s1140-1156.
33. Vickers JC. The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease. Aust N Z J Ophthalmol. 1997;25:105-109.
34. Janciauskiene S, Krakau T. Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol Scand. 2001;79:328-329.
35. Zenkel M, Poschl E, von der Mark K, et al. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2005;46:3742-3752.
36. Berlau J, Lorenz P, Beck R, et al. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin ExpOphthalmol. 2001;239:743-746.
37. Nelson GA, Edward DP, Wilensky JT. Ocular amyloidosis and secondary glaucoma. Ophthalmology. 1999;106:1363-1366.
38. Janciauskiene S, Krakau T. Alzheimer's peptide and serine protein- ase inhibitors in glaucoma and exfoliation syndrome. Doc Ophthal-mol. 2003;106:215-223.